295 related articles for article (PubMed ID: 19132226)
1. Plasminogen activator inhibitor-1: the double-edged sword in apoptosis.
Balsara RD; Ploplis VA
Thromb Haemost; 2008 Dec; 100(6):1029-36. PubMed ID: 19132226
[TBL] [Abstract][Full Text] [Related]
2. The effect of plasminogen activator inhibitor type 1 on apoptosis.
Schneider DJ; Chen Y; Sobel BE
Thromb Haemost; 2008 Dec; 100(6):1037-40. PubMed ID: 19132227
[TBL] [Abstract][Full Text] [Related]
3. Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis.
Leik CE; Su EJ; Nambi P; Crandall DL; Lawrence DA
J Thromb Haemost; 2006 Dec; 4(12):2710-5. PubMed ID: 17010152
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.
Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097
[TBL] [Abstract][Full Text] [Related]
5. [Plasminogen activator system and its clinical significance in patients with a malignant disease].
Halámková J; Kiss I; Tomásek J; Pavlovský Z; Cech Z; Tutek S; Hanáková L; Moulis M; Penka M
Klin Onkol; 2011; 24(6):418-23. PubMed ID: 22257230
[TBL] [Abstract][Full Text] [Related]
6. Anti-apoptotic roles of plasminogen activator inhibitor-1 as a neurotrophic factor in the central nervous system.
Soeda S; Koyanagi S; Kuramoto Y; Kimura M; Oda M; Kozako T; Hayashida S; Shimeno H
Thromb Haemost; 2008 Dec; 100(6):1014-20. PubMed ID: 19132224
[TBL] [Abstract][Full Text] [Related]
7. The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways.
Demyanets S; Kaun C; Rychli K; Rega G; Pfaffenberger S; Afonyushkin T; Bochkov VN; Maurer G; Huber K; Wojta J
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1962-8. PubMed ID: 17604327
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1 inhibits prostate tumor growth through endothelial apoptosis.
Chen SC; Henry DO; Reczek PR; Wong MK
Mol Cancer Ther; 2008 May; 7(5):1227-36. PubMed ID: 18483310
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling.
Stefansson S; McMahon GA; Petitclerc E; Lawrence DA
Curr Pharm Des; 2003; 9(19):1545-64. PubMed ID: 12871067
[TBL] [Abstract][Full Text] [Related]
10. The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes.
Argraves KM; Battey FD; MacCalman CD; McCrae KR; Gåfvels M; Kozarsky KF; Chappell DA; Strauss JF; Strickland DK
J Biol Chem; 1995 Nov; 270(44):26550-7. PubMed ID: 7592875
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin.
Isogai C; Laug WE; Shimada H; Declerck PJ; Stins MF; Durden DL; Erdreich-Epstein A; DeClerck YA
Cancer Res; 2001 Jul; 61(14):5587-94. PubMed ID: 11454712
[TBL] [Abstract][Full Text] [Related]
12. The 'PAI-1 paradox' in vascular remodeling.
Diebold I; Kraicun D; Bonello S; Görlach A
Thromb Haemost; 2008 Dec; 100(6):984-91. PubMed ID: 19132221
[TBL] [Abstract][Full Text] [Related]
13. Regulation of programmed cell death by plasminogen activator inhibitor type 1 (PAI-1).
Lademann UA; Rømer MU
Thromb Haemost; 2008 Dec; 100(6):1041-6. PubMed ID: 19132228
[TBL] [Abstract][Full Text] [Related]
14. Increased intramural expression of plasminogen activator inhibitor type 1 after balloon injury: a potential progenitor of restenosis.
Sawa H; Lundgren C; Sobel BE; Fujii S
J Am Coll Cardiol; 1994 Dec; 24(7):1742-8. PubMed ID: 7963123
[TBL] [Abstract][Full Text] [Related]
15. The Plasminogen-Activator Plasmin System in Physiological and Pathophysiological Angiogenesis.
Ismail AA; Shaker BT; Bajou K
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008762
[TBL] [Abstract][Full Text] [Related]
16. A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target?
Sillen M; Declerck PJ
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800359
[TBL] [Abstract][Full Text] [Related]
17. Atheromatous plaque macrophages produce plasminogen activator inhibitor type-1 and stimulate its production by endothelial cells and vascular smooth muscle cells.
Tipping PG; Davenport P; Gallicchio M; Filonzi EL; Apostolopoulos J; Wojta J
Am J Pathol; 1993 Sep; 143(3):875-85. PubMed ID: 8362983
[TBL] [Abstract][Full Text] [Related]
18. Elevated levels of plasminogen-activator inhibitor type 1 in atherosclerotic aorta.
Shireman PK; McCarthy WJ; Pearce WH; Patterson BK; Shively VP; Cipollone M; Tamarina N; Verrusio EN; Kwaan HC
J Vasc Surg; 1996 May; 23(5):810-7; discussion 817-8. PubMed ID: 8667502
[TBL] [Abstract][Full Text] [Related]
19. Determinants of binding and internalization of tissue-type plasminogen activator by human vascular smooth muscle and endothelial cells.
Grobmyer SR; Kuo A; Orishimo M; Okada SS; Cines DB; Barnathan ES
J Biol Chem; 1993 Jun; 268(18):13291-300. PubMed ID: 7685759
[TBL] [Abstract][Full Text] [Related]
20. [The urokinase-type plasminogen activator system and its role in tumor progression].
Kugaevskaya EV; Gureeva TA; Timoshenko OS; Solovyeva NI
Biomed Khim; 2018 Nov; 64(6):472-486. PubMed ID: 30632975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
